Skip to content

Clinical observation on the safety and efficacy of Mageline anti-aging cream and control products

Clinical observation on the safety and efficacy of Mageline anti-aging cream and control products

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089356
Enrollment
Unknown
Registered
2024-09-06
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged skin

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Healthy women aged 30-65; 2) With obvious wrinkles on the face; 3) Willing to comply with the trial requirements and complete the entire trial for a total of 56 days, and able to complete the follow-up as required. 4) Informed consent of the project and signing informed consent of the project.

Exclusion criteria

Exclusion criteria: 1) Planned pregnancy or pregnant or lactating women; 2) Patients participating in similar clinical observations; 3) Researchers consider other unsuitable patients.

Design outcomes

Primary

MeasureTime frame
crow's feet;Skin elasticity test;Skin roughness test;Dermal thickness and collagen density test;Clinical evaluation;Subject self-assessment and product evaluation;

Secondary

MeasureTime frame
Standard image capture;Skin Gloss Test;Skin corneum moisture test;

Countries

China

Contacts

Public ContactLi Li

West China Hospital, Sichuan University

hxskincosm@qq.com+86 28 8542 2075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026